Myriad Genetics Signs India Deal, Shares Jump
Update: 2025-12-22
Description
Myriad Genetics shares surged 3.7% in afternoon trading after securing an exclusive deal with Zydus Lifesciences to distribute three cancer tests in India. The agreement will provide Indian patients with enhanced diagnostics and treatment plans, while Myriads stock, though volatile, received a positive boost from the news.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
